Anjulika Chawla

454 total citations
21 papers, 290 citations indexed

About

Anjulika Chawla is a scholar working on Genetics, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Anjulika Chawla has authored 21 papers receiving a total of 290 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 9 papers in Hematology and 7 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Anjulika Chawla's work include Hemoglobinopathies and Related Disorders (12 papers), Prenatal Screening and Diagnostics (6 papers) and Iron Metabolism and Disorders (6 papers). Anjulika Chawla is often cited by papers focused on Hemoglobinopathies and Related Disorders (12 papers), Prenatal Screening and Diagnostics (6 papers) and Iron Metabolism and Disorders (6 papers). Anjulika Chawla collaborates with scholars based in United States and Sweden. Anjulika Chawla's co-authors include Carolyn Young, Lewis Glasser, Edwin N. Forman, Phyllis Losikoff, Gail Skowron, James F. Padbury, Victor P. Berardi, Peter J. Krause, Philippa G. Sprinz and Jennifer Welch and has published in prestigious journals such as Blood, The Journal of Immunology and PEDIATRICS.

In The Last Decade

Anjulika Chawla

20 papers receiving 287 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anjulika Chawla United States 8 105 100 80 69 65 21 290
Kinjalka Ghosh India 9 57 0.5× 106 1.1× 68 0.8× 18 0.3× 62 1.0× 23 282
Francesco Massei Italy 12 78 0.7× 79 0.8× 54 0.7× 26 0.4× 183 2.8× 30 432
José Pereira de Moura Neto Brazil 10 146 1.4× 141 1.4× 68 0.8× 35 0.5× 20 0.3× 38 307
Jürgen Sievertsen Germany 9 45 0.4× 34 0.3× 88 1.1× 34 0.5× 35 0.5× 11 184
Chizuko Suzuki Japan 9 28 0.3× 74 0.7× 36 0.5× 177 2.6× 14 0.2× 15 337
Barbara Hannach Canada 11 37 0.4× 124 1.2× 46 0.6× 21 0.3× 37 0.6× 17 331
Hannah Wu United States 9 20 0.2× 44 0.4× 54 0.7× 28 0.4× 163 2.5× 21 275
Graeme Woodfield New Zealand 9 55 0.5× 147 1.5× 25 0.3× 85 1.2× 10 0.2× 15 317
J. G. Gorman United States 11 101 1.0× 212 2.1× 76 0.9× 40 0.6× 22 0.3× 27 409
Smith United Kingdom 8 23 0.2× 147 1.5× 52 0.7× 63 0.9× 13 0.2× 23 328

Countries citing papers authored by Anjulika Chawla

Since Specialization
Citations

This map shows the geographic impact of Anjulika Chawla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anjulika Chawla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anjulika Chawla more than expected).

Fields of papers citing papers by Anjulika Chawla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anjulika Chawla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anjulika Chawla. The network helps show where Anjulika Chawla may publish in the future.

Co-authorship network of co-authors of Anjulika Chawla

This figure shows the co-authorship network connecting the top 25 collaborators of Anjulika Chawla. A scholar is included among the top collaborators of Anjulika Chawla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anjulika Chawla. Anjulika Chawla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kanter, Julie, Melissa A. Kinney, Janet L. Kwiatkowski, et al.. (2024). An Update on Lovotibeglogene Autotemcel (Lovo-cel) Clinical Trials for Sickle Cell Disease (SCD) and Analysis of Early Predictors of Response to Lovo-Cel. Blood. 144(Supplement 1). 511–511. 3 indexed citations
2.
Jaroscak, Jennifer, Julie Kanter, Robert I. Liem, et al.. (2024). Participants with a History of Stroke in Lovotibeglogene Autotemcel (Lovo-cel) Clinical Trials. Blood. 144(Supplement 1). 3576–3576. 1 indexed citations
3.
Kanter, Julie, Anjulika Chawla, Alexis A. Thompson, et al.. (2024). Lovotibeglogene Autotemcel Gene Therapy for Sickle Cell Disease: 60 Months Follow-up. 1(Supplement_1). 1 indexed citations
4.
Herring, William L., Nirmish Shah, Deirdre Mladsi, et al.. (2024). Cost-Effectiveness of Lovotibeglogene Autotemcel (Lovo-Cel) Gene Therapy for Patients with Sickle Cell Disease and Recurrent Vaso-Occlusive Events in the United States. PharmacoEconomics. 42(6). 693–714. 7 indexed citations
5.
Kanter, Julie, Alexis A. Thompson, Janet L. Kwiatkowski, et al.. (2024). Efficacy and Safety in Patients (Pts) with Sickle Cell Disease (SCD) Who Have Received Lovotibeglogene Autotemcel (Lovo-cel) Gene Therapy: Up to 60 Months of Follow-up. Transplantation and Cellular Therapy. 30(2). S230–S231. 1 indexed citations
6.
Kinney, Melissa A., Ilya Shestopalov, Marianna Foos, et al.. (2024). Predictors of Biologic Efficacy with Lovotibeglogene Autotemcel (Lovo-cel) Gene Therapy in Patients with Sickle Cell Disease. Transplantation and Cellular Therapy. 30(2). S231–S232. 1 indexed citations
7.
8.
Chawla, Anjulika, et al.. (2022). Heterogeneity of the long-term economic burden of severe sickle cell disease: a 5-year longitudinal analysis. Journal of Medical Economics. 25(1). 1140–1148. 8 indexed citations
9.
10.
Walters, Mark C., Alexis A. Thompson, Janet L. Kwiatkowski, et al.. (2022). Lovo-cel (bb1111) Gene Therapy for Sickle Cell Disease: Updated Clinical Results and Investigations into Two Cases of Anemia from Group C of the Phase 1/2 HGB-206 Study. Blood. 140(Supplement 1). 26–28. 4 indexed citations
11.
Brown, E. Richard, Anjulika Chawla, Joshua J. Field, et al.. (2020). The Grndad Registry: Contemporary Natural History Data and an Analysis of Real-World Patterns of Use and Limitations of Disease Modifying Therapy in Adults with SCD. Blood. 136(Supplement 1). 34–36. 8 indexed citations
12.
13.
Welch, Jennifer, et al.. (2017). Two cases of humoral hypercalcemia of malignancy complicating infantile fibrosarcoma. Pediatric Blood & Cancer. 64(10). 5 indexed citations
14.
Kahwash, Samir B., et al.. (2017). Refractory cytopenias secondary to copper deficiency in children receiving exclusive jejunal nutrition. Pediatric Blood & Cancer. 64(11). 9 indexed citations
15.
Chawla, Anjulika, Philippa G. Sprinz, Jennifer Welch, et al.. (2013). Weight Status of Children With Sickle Cell Disease. PEDIATRICS. 131(4). e1168–e1173. 47 indexed citations
16.
Young, Carolyn, Anjulika Chawla, Victor P. Berardi, et al.. (2012). Preventing transfusion‐transmitted babesiosis: preliminary experience of the first laboratory‐based blood donor screening program. Transfusion. 52(7). 1523–1529. 60 indexed citations
17.
Halpern, Anna B., et al.. (2008). Prevalence and Complications of Obesity in Sickle Cell Disease.. Blood. 112(11). 1434–1434. 6 indexed citations
18.
Young, Carolyn, Phyllis Losikoff, Anjulika Chawla, Lewis Glasser, & Edwin N. Forman. (2007). Transfusion‐acquired Trypanosoma cruzi infection. Transfusion. 47(3). 540–544. 67 indexed citations
19.
Bhattacharyya, Swati, Anjulika Chawla, Kristofer L. Smith, et al.. (2002). Multilineage Engraftment with Minimal Graft-Versus-Host Disease Following In Utero Transplantation of S-59 Psoralen/Ultraviolet A Light-Treated, Sensitized T Cells and Adult T Cell-Depleted Bone Marrow in Fetal Mice. The Journal of Immunology. 169(11). 6133–6140. 31 indexed citations
20.
Chou, Shiu-Huey, Anjulika Chawla, Tzong‐Hae Lee, et al.. (2001). INCREASED ENGRAFTMENT AND GVHD AFTER IN UTERO TRANSPLANTATION OF MHC-MISMATCHED BONE MARROW CELLS AND CD80low, CD86??? DENDRITIC CELLS IN A FETAL MOUSE MODEL1. Transplantation. 72(11). 1768–1776. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kinjalka Ghosh Breakdown of academic impact, for papers by Francesco Massei Breakdown of academic impact, for papers by José Pereira de Moura Neto Breakdown of academic impact, for papers by Jürgen Sievertsen Breakdown of academic impact, for papers by Chizuko Suzuki Breakdown of academic impact, for papers by Barbara Hannach Breakdown of academic impact, for papers by Hannah Wu Breakdown of academic impact, for papers by Graeme Woodfield Breakdown of academic impact, for papers by J. G. Gorman Breakdown of academic impact, for papers by Smith
Rankless by CCL
2026